CMPX Q2 2025 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$781M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$21M

Net Income

-$20M

EPS (Diluted)

$-0.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$117M

Total Liabilities

$23M

Stockholders' Equity

$93M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$850,000	-100.0%
Gross Profit	$0	$850,000	-100.0%
Operating Income	-$21M	-$15M	-40.0%
Net Income	-$20M	-$13M	-52.0%